tiprankstipranks
Helix BioPharma (TSE:HBP)
TSX:HBP
Canadian Market
Holding TSE:HBP?
Track your performance easily

Helix BioPharma (HBP) Income Statement

25 Followers

Helix BioPharma Income Statement

Last quarter (Q4 2024), Helix BioPharma's total revenue was C$―, a decrease of ― from the same quarter last year. In Q4, Helix BioPharma's net income was C$―. See Helix BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jul 24Jul 23Jul 22Jul 21Jul 20
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 4.08MC$ 9.37MC$ 6.38MC$ 6.06MC$ 9.13MC$ 8.62M
Operating Income
C$ -4.08MC$ -9.37MC$ -6.38MC$ -6.06MC$ -9.13MC$ -8.62M
Net Non Operating Interest Income Expense
C$ 5.00KC$ 24.00KC$ 33.00KC$ -14.00KC$ 353.00K-
Other Income Expense
C$ -106.00KC$ -132.00KC$ 3.00KC$ 501.00KC$ -90.00KC$ 55.00K
Pretax Income
C$ -3.99MC$ -9.26MC$ -6.29MC$ -6.59MC$ -9.57MC$ -8.56M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -3.99MC$ -9.26MC$ -6.29MC$ -6.59MC$ -8.04MC$ -8.98M
Basic EPS
C$ -0.11C$ -0.21C$ -0.03C$ -0.04C$ -0.06C$ -0.07
Diluted EPS
C$ -0.11C$ -0.21C$ -0.03C$ -0.04C$ -0.06C$ -0.07
Basic Average Shares
C$ 635.86MC$ 44.49MC$ 193.23MC$ 149.49MC$ 137.89MC$ 127.71M
Diluted Average Shares
C$ 635.86MC$ 44.49MC$ 193.23MC$ 149.49MC$ 137.89MC$ 127.71M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
---C$ 6.06MC$ -9.13MC$ -8.62M
Net Income From Continuing And Discontinued Operation
C$ -3.99MC$ -9.26MC$ -6.29MC$ -6.59MC$ -8.04MC$ -8.98M
Normalized Income
C$ -3.95MC$ -9.17MC$ -4.63MC$ -4.84MC$ -7.04MC$ -6.29M
Interest Expense
------
EBIT
C$ -3.96MC$ -9.26MC$ -6.28MC$ -6.57MC$ -9.56MC$ -8.54M
EBITDA
C$ -3.95MC$ -9.26MC$ -6.26MC$ -6.56MC$ -9.36MC$ -8.32M
Currency in CAD

Helix BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis